Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis
Open Access
- 10 March 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (3) , e17797
Abstract
Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially in adolescents and adults, has increased in several countries despite high vaccination coverage. During the last three decades, strains of Bordetella pertussis in circulation have shifted from the vaccine-type to the nonvaccine-type in many countries. A comparative proteomic analysis of the strains was performed to identify protein(s) involved in the type shift. Proteomic analysis identified one differentially expressed protein in the B. pertussis strains: the type III cytotoxic effector protein BteA, which is responsible for host cell death in Bordetella bronchiseptica infections. Immunoblot analysis confirmed the prominent expression of BteA protein in the nonvaccine-type strains but not in the vaccine-type strains. Sequence analysis of the vaccine-type strains revealed an IS481 insertion in the 5′ untranslated region of bteA, −136 bp upstream of the bteA start codon. A high level of bteA transcripts from the IS481 promoter was detected in the vaccine-type strains, indicating that the transcript might be an untranslatable form. Furthermore, BteA mutant studies demonstrated that BteA expression in the vaccine-type strains is down-regulated by the IS481 insertion. The cytotoxic effector BteA protein is expressed at higher levels in B. pertussis nonvaccine-type strains than in vaccine-type strains. This type-dependent expression is due to an insertion of IS481 in B. pertussis clinical strains, suggesting that augmented expression of BteA protein might play a key role in the type shift of B. pertussis.Keywords
This publication has 45 references indexed in Scilit:
- Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopNJournal of Experimental Medicine, 2009
- TheBordetellatype III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid raftsCellular Microbiology, 2009
- Virulence factor secretion and translocation by Bordetella speciesCurrent Opinion in Microbiology, 2009
- Bordetella Bsp22 forms a filamentous type III secretion system tip complex and is immunoprotective in vitro and in vivoMolecular Microbiology, 2009
- Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune ResponsesInfection and Immunity, 2008
- Pulsed-Field Gel Electrophoresis, Pertactin, Pertussis Toxin S1 Subunit Polymorphisms, and Surfaceome Analysis of Vaccine and Clinical Bordetella pertussis StrainsClinical and Vaccine Immunology, 2007
- Type III Secretion Systems and DiseaseClinical Microbiology Reviews, 2007
- Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine StrainsClinical and Vaccine Immunology, 2007
- Differential In Vitro Expression of the brkA Gene in Bordetella pertussis and Bordetella parapertussis Clinical IsolatesJournal of Clinical Microbiology, 2006
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005